Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid TumorsEntrectinib in NTRK+ Solid Tumors: Updated Efficacy/Safety

Overview of attention for article published in Clinical Cancer Research, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 121 X posts from 86 X users, with an upper bound of 346,985 followers.

RT @Marlowe_Tessmer: ICYMI from tonight's @AACR #sarcoma conference keynote speaker - Updated Integrated Analysis of the Efficacy and Safet…

RT @Marlowe_Tessmer: ICYMI from tonight's @AACR #sarcoma conference keynote speaker - Updated Integrated Analysis of the Efficacy and Safet…

RT @Marlowe_Tessmer: ICYMI from tonight's @AACR #sarcoma conference keynote speaker - Updated Integrated Analysis of the Efficacy and Safet…

RT @Marlowe_Tessmer: ICYMI from tonight's @AACR #sarcoma conference keynote speaker - Updated Integrated Analysis of the Efficacy and Safet…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 117 additional X posts.